GFAP and peripheral nerve injury: Comparing the sources of equine MSCs subjected to the induction medium, we observed that the gene expression of GFAP and S100β was significantly higher in equine AT-MSCs, which is the best candidate for cell-based therapy in the context of peripheral nerve injuries.